Pioneering vision restoration therapies for severe retinal degenerations.
About
Ray Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies to restore vision for individuals suffering from severe retinal degenerations. Their approach aims to address unmet medical needs in ophthalmology.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Ray Therapeutics do?
Ray Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies to restore vision for individuals suffering from severe retinal degenerations. Their approach aims to address unmet medical needs in ophthalmology.
How much funding has Ray Therapeutics raised?
Ray Therapeutics has raised a total of $243M in funding. The most recent round on record is Series B.
Where is Ray Therapeutics headquartered?
Ray Therapeutics is headquartered in Berkeley, California, USA.
When was Ray Therapeutics founded?
Ray Therapeutics was founded in 2021.
What industry does Ray Therapeutics operate in?
Ray Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare, Medical Devices, Biotech, Drug Discovery.
Similar Startups